Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer

por Mansour, W. Y., Tennstedt, P., Volquardsen, J., Oing, C., Kluth, M., Hube-Magg, C., Borgmann, K., Simon, R., Petersen, C., Dikomey, E., Rothkamm, K.
Publicado 2018